Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors

Clinical trial NCT05278208 · RECRUITING

Trial details

NCT number: NCT05278208
Sponsor: Nationwide Children's Hospital
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

High Grade Glioma Meningioma Embryonal Tumor Medulloblastoma Anaplastic Ependymoma Recurrent Diffuse Intrinsic Pontine Glioma Recurrent Malignant Glioma Recurrent Medulloblastoma Recurrent Primary Central Nervous System Neoplasm Refractory Diffuse Intrinsic Pontine Glioma Refractory Malignant Glioma Refractory Medulloblastoma

Start date: 2022-11-21
Primary completion: 2028-11-01
Enrollment: 65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.